Extending the Spectrum of Massive Perivillous Fibrin Deposition (Maternal Floor Infarction)

Faye-Petersen OM Ernst LM. Maternal floor infarction and massive perivillous fibrin deposition. Surg Pathol Clin. 2013; 6(1):101–114.

Redline RW. Invited commentary—maternal floor infarction and massive perivillous fibrin deposition: clinicopathologic entities in flux. Adv Anat Pathol. 2002; 9:372–373.

Becroft DM Thompson JM Mitchell EA. Placental infarcts, intervillous fibrin plaques, and intervillous thrombi: incidences, cooccurrences, and epidemiological associations. Pediatr Dev Pathol. 2004; 7(1):26–34.

Weber MA Nikkels PG Hamoen K Duvekot JJ de Krijger RR. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report. Pediatr Dev Pathol. 2006; 9(3):234–238.

Griffin AC Strauss AW Bennett MJ Ernst LM. Mutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition. Pediatr Dev Pathol. 2004; 15(5):368–374.

Bendon RW Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med. 1996; 16:293–297.

Katz VL DiTomasso J Farmer R Carpenter M. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol. 2002; 19(5):273–277.

Mandsager NT Bendon RW Mostello D Rosenn B Miodovnik M Siddiqi TA. Maternal floor infarction of placenta: prenatal diagnosis and clinical significance. Obstet Gynecol. 1994; 83:750–754.

Sebire NJ Backos M Goldin RD Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. Br J Obstet Gynaecol. 2002; 109(5):570–573.

Kim EN Lee JY Shim JY , et al. Clinicopathological characteristics of miscarriages featuring placental massive perivillous fibrin deposition. Placenta. 2019; 86:45–51.

Feuer R Mena I Pagarigan RR Harkins S Hassett DE Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol. 2003; 163(4):1379–1393.

Feist H Turowski G Hussein K Blocker T Heim A. Massive perivillous fibrin deposition of an enterovirus A-infected placenta associated with stillbirth: a case report. Pediatr Dev Pathol. 2019; 22(2):142–145.

Yu W Tellier R Wright JR Jr. Coxsackie virus A16 infection of placenta with massive perivillous fibrin deposition leading to intrauterine fetal demise at 36 weeks gestation. Pediatr Dev Pathol. 2015; 18(4):331–334.

Vivanti AJ Vauloup-Fellous C Prevot S , et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020; 11(1):3572.

Hosier H Farhadian SF Morotti RA , et al. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020; 130(9):4947–4953.

Baergen RN, Heller DS. Placental pathology in Covid-19 positive mothers: preliminary findings. Pediatr Devel Pathol. 2020; 23: 177–180.

Shanes, ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental pathology in COVID-19. Am J Clin Pathol. 2020; 154: 23–32.

Algarroba GN Rekawek P Vahanian SA , et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy. Am J Obstet Gynecol. 2020; 223(2):275–278.